Reports fourth quarter 2020 revenue of $8.5 million, GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.07Reports combined cash and investments of $52.0 million as of December 31, 2020 WINTER SPRINGS, Fla., Feb. 04, 2021 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., Jan. 27, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market opens on Thursday, February 4th. IRADIMED management will host a conference call the...

Reports third quarter 2020 revenue of $7.7 million, GAAP diluted EPS of $0.09 and non-GAAP diluted EPS of $0.11Reports combined cash and investments of $49.9 million as of September 30, 2020 WINTER SPRINGS, Fla., Oct. 30, 2020 -- iRadimed Corporation (the "Company")...

WINTER SPRINGS, Fla., Oct. 08, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens on Friday, October 30th. IRADIMED management will host a conference call the same...

Reports second quarter 2020 revenue of $6.8 million, GAAP diluted EPS of $(0.17) and non-GAAP diluted EPS of $0.05Reports combined cash and investments of $47.8 million as of June 30, 2020 WINTER SPRINGS, Fla., July 30, 2020 -- iRadimed Corporation (the "Company")...

WINTER SPRINGS, Fla., July 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market opens on Thursday, July 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., May 29, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company's President and Chief Executive Officer after the departure of Leslie McDonnell, who...

Latest patent expands previous claims around IRADIMED's wireless communication as used to remotely control an IV pumpWINTER SPRINGS, Fla., May 11, 2020 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a...

Reports first quarter 2020 revenue of $8.7 million, GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.18Reports combined cash and investments of $47.4 million as of March 31, 2020 WINTER SPRINGS, Fla., April 30, 2020 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., April 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before the market opens on Thursday, April 30th. iRadimed management will host a conference call the same...